|
A more recent version of this article appeared on December 1, 2002
Papers In Press, published online ahead of print September 16, 2002
J. Lipid Res., doi:10.1194/jlr.M200285-JLR200
Submitted on July 19, 2002
Revised on September 11, 2002
Accepted on September 11, 2002
Evidence for Vesicles That Mediate Long-chain Fatty Acid Uptake by Human Microvascular Endothelial Cells
Axel Ring, Jürgen Pohl, Alfred Völkl, and Wolfgang Stremmel
Internal Medicine 4, University Hospital Heidelberg, Heidelberg 69115
Corresponding Author: axel_ring{at}med.uni-heidelberg.de
This study analyzes the mechanisms of long-chain fatty acid (LCFA) uptake by human microvascular endothelial cells (HMEC). The time course revealed the presence of an early, carrier-mediated uptake component and a later component mediated by clathrin-coated vesicles (CCV) and caveolae, as evidenced by three different experimental approaches: 1. Significant reduction of [3H] oleate uptake over 5 minutes by either inhibition of CCV formation by potassium depletion or hypertonic medium, or disruption of caveolae by filipin III or cyclodextrin. 2. Co-localization of intracellular 12-(N-methyl)-N-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]octadecanoic acid with CCV and caveolae using confocal laser scanning microscopy. 3. Enrichment of [3H] oleate in a subcellular fraction containing CCV and caveolae. Within 10 minutes, more than 75% of intracellular [3H] oleate remained unmetabolized suggesting that HMEC preferentially shuttle LCFA through the cell using CCV and caveolae as carriers. The uptake of albumin paralleled that of oleate within the first 10 minutes suggesting internalization of at least some LCFA bound to albumin. Compared to oleate and albumin, the uptake of sucrose and dextran was low indicating a potential minor contribution of fluid-phase endocytosis to the total vesicular LCFA uptake. The data indicate a previously unrecognized role of both CCV and caveolae for the uptake of LCFA by HMEC.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Kiens
Skeletal Muscle Lipid Metabolism in Exercise and Insulin Resistance
Physiol Rev,
January 1, 2006;
86(1):
205 - 243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Pohl, A. Ring, U. Korkmaz, R. Ehehalt, and W. Stremmel
FAT/CD36-mediated Long-Chain Fatty Acid Uptake in Adipocytes Requires Plasma Membrane Rafts
Mol. Biol. Cell,
January 1, 2005;
16(1):
24 - 31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Roepstorff, B. Vistisen, K. Roepstorff, and B. Kiens
Regulation of plasma long-chain fatty acid oxidation in relation to uptake in human skeletal muscle during exercise
Am J Physiol Endocrinol Metab,
October 1, 2004;
287(4):
E696 - E705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Vistisen, K. Roepstorff, C. Roepstorff, A. Bonen, B. van Deurs, and B. Kiens
Sarcolemmal FAT/CD36 in human skeletal muscle colocalizes with caveolin-3 and is more abundant in type 1 than in type 2 fibers
J. Lipid Res.,
April 1, 2004;
45(4):
603 - 609.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|